Marcie A Glicksman
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2023First federal award
$4.1MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $4.1M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 17, 2025 | NIH | SBIR Phase I Smart CSF Delivery System for CNS Drug Therapy for Leptomeningeal Disease | $150K | ENCLEAR THERAPIES, INC. |
| Jul 15, 2025 | NIH | SBIR Phase I Smart CSF Delivery System for CNS Drug Therapy for Leptomeningeal Disease | $108K | ENCLEAR THERAPIES, INC. |
| 2025 | NIH | SBIR Phase II Targeted Cerebral Spinal Fluid (CSF) Drug Delivery - Enclear Precision System | $3.0M | ENCLEAR THERAPIES, INC. |
| Aug 8, 2024 | NIH | SBIR Phase II Targeted Cerebral Spinal Fluid (CSF) Drug Delivery - Enclear Precision System | $93K | ENCLEAR THERAPIES, INC. |
| Jun 18, 2024 | NIH | SBIR Phase I Smart CSF Delivery System for CNS Drug Therapy for Leptomeningeal Disease | $296K | ENCLEAR THERAPIES, INC. |
| Dec 28, 2023 | NIH | SBIR Phase II Targeted Cerebral Spinal Fluid (CSF) Drug Delivery - Enclear Precision System | $495K | ENCLEAR THERAPIES, INC. |
Peer ranks
Federal funding#402
Awards as PI#349
Patents#505
Companies
- ENCLEAR THERAPIES, INC.Linked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.